Efficacy Study of the Medical Device TRP Snorless™ in the Treatment of Snoring

Inclusion Criteria:

• Man or woman ≥ 18 years and ≤ 65 years at the time of signing informed consent

• Listed as continuous snorer (snoring at least 4 nights/week)

• Answer "Extremely loud" or "very loud" to question 1 of SBPS at screening

• Answer "very severe" or "severe" to question 2 of SBPS at screening

• Answer "extremely" or "quite a bit" to question 3 of SBPS at screening

• Dated and signed informed consent

• BMI ≤ 35

Exclusion Criteria:

• Severe Mandibular retrognathia and micrognathia

• Narrow and deep palate (less than 3 cm wide)

• Lack of three consecutive teeth in the area of (15-16-17-18) or (25-26-27-28).

• Lingual or labial short frenulum (the tongue cannot reach the upper incisors whenmouth can be opened for two fingers)

• Intolerable gag reflex

• Known nasal septal deviation

• Neck circumference > 46 cm

• Patient currently treated for OSA

• Patient with AHI≥30 events/hour or with AHI>15 and (SFI) Sleep Fragmentation Index > 20

• Patient currently treated for central sleep apnoea

• Addiction to alcoholic beverages (5 drinks per day per NIAAA)

• Under constant pharmacological treatment for depression, anxiety, chronic pain,insomnia

• Hypertrophy of tonsils

• Macroglossia

• Hypertrophy of uvula

• Primary gastroesophageal reflux

• Any other pathology preventing subject from complying with the protocol

• Subject with recent oropharyngeal surgery or likely during the study

• Mental inability, unwillingness or language barrier precluding adequate understandingof or compliance with study procedures

• Pregnancy

• Patient with severe Chronic Obstructive Pulmonary Disease

• Asthmatic patient under inhaled corticoid therapy